Individuals who are appointed to serve on ABIM boards or committees are expected to have ABIM's mission as their primary interest when contributing to ABIM's work and therefore must adhere to our Board Policies.
Yul Ejnes, MD, Chair
Dr. Ejnes, a board certified internal medicine specialist, is in private practice at Coastal Medical in Cranston, Rhode Island, which he co-founded in 1995. Coastal Medical is Rhode Island's largest private practice, a Level 3 Patient Centered Medical Home, and a Medicare accountable care organization.
In addition to practicing full-time, Dr. Ejnes is Clinical Associate Professor of Medicine at the Warren Alpert Medical School of Brown University. He is a member and past Chair of the Board of Directors of the Rhode Island Quality Institute, the state's designated regional health information organization. He is also a member of the American College of Physicians' (ACP) delegation to the American Medical Association (AMA) House of Delegates.
At ACP, Dr. Ejnes has served as Chair of the Board of Regents, Chair of the Board of Governors, Rhode Island Chapter Governor, and as member or Chair of numerous committees and task forces. He recently completed a term on the AMA Relative Value Scale Update Committee. He serves as Chair-elect of the American Board of Internal Medicine's Board of Directors, and is also a member of ABIM's Internal Medicine Specialty Board. He was also past President of the Rhode Island Medical Society and the Rhode Island Society of Internal Medicine.
Dr. Ejnes earned his medical degree from Brown Medical School in Providence, Rhode Island in 1985 and did his internal medicine residency and chief medical residency at Rhode Island Hospital, also in Providence.
As of April 2021, Dr. Ejnes reported the following external relationships:
Dr. Ejnes serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American College of Physicians, Medical Informatics Subcommittee; American Medical Association House of Delegates; Rhode Island Chapter, Executive Council and Program Committee, receiving reimbursement for travel expenses.
Rajeev Jain, MD, Chair-Elect
Dr. Jain is a board certified gastroenterologist who has been in private practice in Dallas, Texas since 1999. He is a partner at Texas Digestive Disease Consultants and serves as Chief of Gastroenterology at Texas Health Presbyterian Hospital in Dallas. He is also a Clinical Associate Professor of Medicine at The University of Texas Southwestern Medical School.
Dr. Jain is a member of the American Board of Internal Medicine Board of Directors. He served on the American Gastroenterological Association (AGA) Governing Board as a Clinical Councilor and Chair of the AGA Practice Management and Economics Committee. He has participated in clinical guideline development at both the AGA and American Society of Gastrointestinal Endoscopy (ASGE), where he served on the Standards of Practice Committee from 2008-2010. Additionally, Dr. Jain was a member of the task force that created the AGA colonoscopy bundle framework, and was co-Director of the GI Outlook 2013 Practice Management Course co-sponsored by the AGA and ASGE. Dr. Jain is a Fellow of the American College of Physicians, AGA and ASGE.
Dr. Jain received his bachelor's degree in chemical engineering from The University of Texas at Austin and his medical degree from Baylor College of Medicine. He completed his residency training in internal medicine and fellowship in gastroenterology at The University of Texas Southwestern Medical School in Dallas, Texas.
As of July 2020, Dr. Jain reported the following external relationships:
Funding for clinical trial expenses, salary support and staff, paid to Texas Digestive Disease Consultants, from the following companies:
- AbbVie, for a trial on induction and maintenance therapy for moderately to severely active ulcerative colitis, and for two trials on Crohn’s Disease.
- Eli Lilly & Company, for a trial on ulcerative colitis.
- Gilead, for trials on ulcerative colitis and Crohn’s Disease.
- Janssen, for a trial on induction and maintenance therapy for moderately to severely active ulcerative colitis.
- Roche, for a trials on Crohn’s Disease and on ulcerative colitis.
- Takeda, for a trials on Crohn’s Disease and on ulcerative colitis.
Dr. Jain also reported receiving reimbursement from Texas Health-Dallas for coordinating lectures for residents and staff as Chief of Gastroenterology. He reported that he serves on the clinical governing board of his practice.
Robert O. Roswell, MD, Secretary
Dr. Robert Roswell is Associate Dean for Diversity and Inclusion at the Zucker School of Medicine at Hofstra/Northwell where he also serves as Associate Professor of Science Education & Cardiology. Board certified in internal medicine and cardiovascular diseases, he is co-Director of the Cardiac ICU and the Associate Cardiology Fellowship Director at Northwell Health's Lenox Hill Hospital. Dr. Roswell serves as a member of the American Board of Internal Medicine Board of Directors.
A champion of promoting equity in medicine, Dr. Roswell is a graduate of the American Association of Medical College's Healthcare Executive Diversity and Inclusion Certificate program and has worked to integrate the social determinants of health, implicit bias, and cultural humility into the medical education curriculum. He has been awarded the Certificate of Appreciation from the Student National Medical Association and an Outstanding Mentorship Award from Internal Medicine Residents for his role in medical education.
Dr. Roswell's academic focus is at the nexus of acute cardiac care and health care disparities. Earlier in his career, he was honored by the American Heart Association and was a recipient of the Young Heart Award for outstanding care to patients. He is on the Steering Committee for the Critical Care Cardiology Trials Network and is active in the leadership of the American College of Cardiology as a New York Councilor and chair of the New York Diversity & Inclusion Taskforce. He is also a member of the Association of Black Cardiologists and is a strong advocate for health equity by providing high-quality, evidence-based care delivered with cultural humility to all patients.
His medical degree was conferred with honors from New York University School of Medicine where he completed residency and chief residency. He went on to fellowship at Georgetown University School of Medicine/Washington Hospital Center. Throughout his career, Dr. Roswell has given numerous talks and authored several publications on acute cardiac care, cardiogenic shock, and health care disparities.
As of August 2020, Dr. Roswell reported the following external relationships:
Dr. Roswell serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American College of Cardiology, Councilor, Board of Trustee, Equality Taskforce, without compensation.
Sonia A. Madison, MS, Treasurer
Ms. Madison served as Senior Vice President for Public Policy for AmeriHealth Mercy Family of Companies (AMFC). In this role, she was responsible for establishing the AMFC public policy agenda. Ms. Madison and her team monitored and evaluated health policy developments and trends, helping to establish AMFC's strategic direction and advocating for policies and programs that would benefit members.
Ms. Madison previously served as AMFC's interim Chief Executive Officer for LaCare, the Louisiana expansion plan. She played a critical role in working with policy makers, state government and the provider community and stakeholders to successfully implement the Louisiana line of business.
Ms. Madison served as Senior Advisor to the Secretary, US Department of Health and Human Services. In this role, she had responsibility and authority to represent Secretary Leavitt in the redesign and rebuild of the Louisiana health care system with primary focus on the greater New Orleans area. Prior to this role, she served as Senior Vice President, Sales and Marketing for AmeriChoice, a UnitedHealth Group company. Preceding that, she was Chief Executive Officer for AmeriChoice of Pennsylvania, Inc. Prior to her role with AmeriChoice, Ms. Madison served as the Regional Administrator of the Centers for Medicare & Medicaid Services, Philadelphia regional office, where she was responsible for oversight of regional office operations, as well as guiding and coordinating policies for the Medicare, Medicaid and State Children's Health Insurance Programs. Before that, she was President and Chief Executive Officer of Health Partners, a managed care organization serving the Medicare and Medicaid population in Philadelphia.
With more than 30 years of health care and management experience to her credit, Ms. Madison is regarded as a leader in the health care field. Her knowledge of federal and state health care programs and policy is coupled with a keen focus on quality of care, access to services for underserved populations, outreach and education to the provider community. She is currently a member of the American Board of Internal Medicine Board of Directors.
Ms. Madison received a bachelor's degree in human services from Antioch University and a master's degree from Drexel University in Philadelphia.
As of May 2020, Ms. Madison reported no external relationships.
Richard J. Baron, MD, President & CEO
Dr. Baron, board certified in Internal Medicine and Geriatrics, is President and Chief Executive Officer of the American Board of Internal Medicine (ABIM) and the ABIM Foundation. Dr. Baron was a former Chair of the ABIM's Board of Directors and served on the ABIM Foundation Board of Trustees.
Previously, Dr. Baron served as Group Director of Seamless Care Models at the Centers for Medicare & Medicaid Services (CMS) Innovation Center, where he led efforts related to accountable care organizations and primary care. Prior to his CMS appointment, Dr. Baron practiced general internal medicine and geriatrics for almost 30 years at Greenhouse Internists, P.C., located in Philadelphia. Greenhouse was a pioneer in the comprehensive adoption of electronic health records in the small-practice environment. Until joining the federal government, Dr. Baron also served on the board of the National Quality Forum and their Health Information Technology Advisory Committee, as well as the Standards Committee of the National Committee for Quality Assurance.
Dr. Baron served as Chief Medical Officer of Health Partners, a not-for-profit Medicaid HMO set up by four teaching hospitals in Philadelphia, from 1988 to 1996. He was the architect of the Best Clinical and Administrative Practices program, funded by the Robert Wood Johnson Foundation and the Center for Health Care Strategies, working with medical leadership of Medicaid health plans around the country in learning collaboratives to improve the quality of care for their members. This program reached plans serving more than half of the Medicaid managed care population in the United States.
Dr. Baron received an English degree from Harvard College and his medical degree from Yale University. He completed house staff training at New York University-Bellevue Medical Center and served a three-year obligation in the National Health Service Corps in rural Tennessee.
As of July 2020, Dr. Baron reported no external relationships.
Vineet Arora, MD
Dr. Arora, a board certified internist, is an academic hospitalist, Dean for Medical Education of the University of Chicago Biological Sciences Division (BSD). In the latter role, she bridges educational and hospital leadership to integrate residents and fellows into the quality, safety and value missions of the institution. Through the Agency for Healthcare Research & Quality, National Institutes of Health and ABIM Foundation funding, she has developed and evaluated novel interventions that combine systems change with adult learning theory to improve care and learning in teaching hospitals. She has authored more than 100 peer-reviewed publications, with coverage in The New York Times, National Public Radio and the Associated Press.
As the Director of Educational Initiatives at Costs of Care, she co-chaired the Teaching Value and Choosing Wisely® Challenge and co-authored Understanding Value-Based Healthcare. For her work, she has received the American College of Physicians Walter J. McDonald Young Physician Award, the Society of Hospital Medicine's Excellence in Hospital Medicine Research Award and the Society of General Internal Medicine's Frederick L. Brancati Leadership and Mentorship Award. In 2011, she was named to 20 People Who Make American Healthcare Better by HealthLeaders Magazine. She is a member of the American Board of Internal Medicine Board of Directors.
Dr. Arora earned her medical degree at the Washington University in St. Louis and completed her residency, chief residency and master's degree in public policy at the University of Chicago. Dr. Arora regularly tweets about medical education, technology and health policy at @futuredocs.
As of August 2020, Dr. Arora reported the following external relationships:
Work as an author with royalties or other compensation from the following companies:
- Royalties from UpToDate®
Dr. Arora serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Society of Hospital Medicine, serving as Deputy Social Media Editor, Journal of Hospital Medicine, receiving honoraria.
- The Joint Commission, serving as Board Member, receiving honoraria and reimbursement for travel expenses.
Dr. Arora receives funding from the following nonprofit healthcare-related organizations:
- ABIM Foundation, receiving funding from the Costs of Care, paid to the University of Chicago.
- Accreditation Council for Graduate Medical Education, receiving funding through the Pursuing Excellence in Clinical Learning Environments Initiative to transform graduate medical education to promote exemplary clinical learning environments.
- American Medical Association, receiving funding to promote curricular change in value, improvement, safety, team training and advocacy for Pritzker School of Medicine.
M. Safwan Badr, MD
Dr. Badr is Professor and Chair of the Wayne State University (WSU) School of Medicine Department of Internal Medicine. He is also a Professor of Physiology and Biomedical Engineering, and a staff physician at the John D. Dingell VA Medical Center. Dr. Badr is board certified in Internal Medicine, Pulmonary Disease, Critical Care Medicine and Sleep Medicine.
Previously, Dr. Badr served as Chief, Division of Pulmonary, Critical Care and Sleep Medicine at WSU School of Medicine (1998-2017), Associate Chair of the Department of Internal Medicine (2004-2008), Chief Medical Officer of the Detroit Medical Center (2008-2010), Board of Directors, DMC’ s Michigan Pioneer Accountable Care Organization (2013-2017) and Chief Medical Officer of the Wayne State University Physician Group (2016-2017).
He has also served on multiple national and international medical societies. Dr. Badr is a member of the American Board of Internal Medicine Board of Directors. Previously, he served on the Boards of Directors of the American Thoracic Society
Dr. Badr is an internationally known sleep disorders researcher and research mentor. He has mentored numerous trainees and junior faculty members who have launched successful academic careers.
Dr. Badr is invested in outstanding medical education. He was the founding director of the WSU Sleep Medicine Fellowship program, and he teaches and mentors students, residents and fellows in multiple departments across the medical school.
A graduate of Damascus University Medical School, Dr. Badr completed a residency in internal medicine at Cook County Hospital in Chicago, Illinois, followed by clinical and research fellowships in pulmonary, critical care and sleep medicine at the University of Wisconsin, Madison. In addition, he completed a Master of Business Administration degree at the University of Tennessee.
As of September 2020, Dr. Badr reported the following external relationships:
Work as an author or editor for following company, with compensation as listed:
- UpToDate®, receiving compensation for authorship relating to sleep medicine topics.
Dr. Badr also reported serving on two editorial boards.
Roger W. Bush, MD
Dr. Bush, a board certified internist, is the Internal Medicine Residency Development Director at the Washington State University Elson S. Floyd College of Medicine, with a focus on developing the care and learning model for general internists in rural and underserved communities. He was Founding Program Director of the Billings Clinic Internal Medicine Residency, the first of its kind in this vast, rural, underserved area. He is a Master of the American College of Physicians (ACP) and a Senior Fellow in Hospital Medicine (Society of Hospital Medicine). His core professional interest is the design and implementation of waste-free, highly reliable clinical microsystems around the needs and preferences of patients, with clinical education and quality improvement integrated in the daily work.
He served as the Program Director for the internal medicine residency at Virginia Mason Medical Center from 1996-2007. He practiced primary care internal medicine for many years at Virginia Mason Medical Center in Seattle, after entering primary care practice in Newport, Oregon. As Founding Program Director of the Billings Clinic Internal Medicine Residency, Dr. Bush guided its mission to bring general internists to the region within 600 miles of Billings, Montana (Eastern Montana, Western North Dakota and Northern Wyoming).
In 2011, Dr. Bush accepted ACP's appointment to the Board of Commissioners of The Joint Commission, where he chaired the Achieving High Reliability in Healthcare Strategic Interest Workgroup, and also served on the Accreditation, Performance Measurement and Governance Committees. From January 2002 to June 2009, he served on Accreditation Council for Graduate Medical Education's Residency Review Committee for Internal Medicine (RRC-IM), appointed by the ACP. He chaired the Educational Innovation Project Subcommittee of RRC-IM, a multiyear effort to change from process-based to outcomes-based accreditation and collaboratively align educational and quality of care outcomes. Dr. Bush is a member of the American Board of Internal Medicine (ABIM) Board of Directors and serves on the ABIM Internal Medicine Board. He also serves as a Director for the American Board of Family Medicine.
He received his medical degree from the University of California, San Francisco, and completed internal medicine residency in 1983 at Virginia Mason Medical Center in Seattle.
As of March 2020, Dr. Bush reported the following external relationships:
Dr. Bush serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American College of Physicians, faculty for annual session, with honoraria donated to American College of Physicians Educational Programs.
- The Joint Commission, serving on the Board of Commissioners, and as a committee Chair and committee member, without compensation.
- American Board of Family Medicine, serving as Director and examination and communications committee member, receiving honoraria and reimbursement for travel expenses.
Dr. Bush also reported service as Professor of Clinical Medicine for Washington State University, Elson S. Floyd College of Medicine Graduate Medical Education division; tasked to develop an Internal Medicine Residency Program to prepare general internists to serve rural and underserved populations.
Carladenise Edwards, Ph.D
Dr. Edwards serves as Executive Vice President/Chief Strategy Officer at Henry Ford Health System. She provides executive counsel and leadership for the system's strategic transformational initiatives, partnership ventures, business development, government affairs, as well as Henry Ford Innovations, a multi-disciplinary team responsible for product design and commercialization, technology transfer, licensing agreements and international programs.
Dr. Edwards has nearly three decades of healthcare, nonprofit and government experience. Additional executive leadership roles include chief strategy officer for Providence St. Joseph Health (2016-2020) and Alameda Health System (2013-2016). She served as Founding President and Chief Executive Officer (CEO) of a nonprofit corporation, which governed California's Electronic Health Information Exchange, held leadership roles in Georgia's Department of Community Health, and advised healthcare, technology and nonprofit clients as Principal Advisor and CEO with a Florida based consulting firm.
She has a doctorate in medical sociology from the University of Florida, a master's degree in education and psychological services and bachelor's degree in sociology from the University of Pennsylvania.
As of July 2021, Dr. Edwards reported the following external relationships:
COI Info Coming Soon
Alicia Fernandez, MD
Dr. Alicia Fernandez is Professor of Medicine at University of California, San Francisco (UCSF) and a board-certified internist at Zuckerberg San Francisco General Hospital where she practices primary care medicine and attends on the medical wards. Her research is in health and health care disparities, with a focus on diabetes, Latino health, immigrant health, and language barriers.
A member of the UCSF Academy of Medical Educators, she received the Arnold P. Gold Foundation Professorship for Humanism in Medicine (2009-2013). Since 2014, Dr. Fernandez has been a member of the Board of Governors of the Patient Centered Outcomes Research Institute (PCORI) and the National Academy of Science Roundtable on Health Literacy. She is co-editor of the Lange textbook (second edition, 2016), Medical Management of Vulnerable and Underserved Patients.
Dr. Fernandez received her bachelor degree at Yale, her medical degree from the Albert Einstein College of Medicine and completed her residency, chief residency and fellowship at UCSF.
As of July 2020, Dr. Fernandez reported the following external relationships:
Work as an author or editor for following companies, with compensation as listed:
- Lange, receiving compensation for work as an editor.
Dr. Fernandez serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Patient-Centered Outcomes Research Institute, Board of Governors, receiving honoraria and reimbursement for travel expenses.
Grant funding for salary support, paid to the University of California, San Francisco, from the following nonprofit healthcare-related organizations:
- Health Resources and Services Administration
- National Institutes of Health
- Greenwall Bioethics Foundation
Marianne M. Green, MD
Dr. Green, board certified in Internal Medicine, is Senior Associate Dean for Medical Education at the Northwestern University Feinberg School of Medicine and the Raymond H. Curry MD Professor of Medical Education.
Over the course of her career, she has led several education initiatives, most recently as Administrative Leader for the Competency-Based Education Initiative at Feinberg School of Medicine. Her academic interest is in the use of portfolios and narrative for competency assessment. She has received numerous awards and honors, including the Harvard Macy Fellowship for Assessment in Medical Education and the George H. Joost Outstanding Teacher Award. Dr. Green is also an inaugural member of the Feinberg Academy of Medical Educators. In addition to her academic roles, Dr. Green directs patient care at the outpatient General Internal Medicine Clinic.
Dr. Green is the immediate past Chair of American Board of Internal Medicine's (ABIM) Board of Directors. She previously served as Council Director on the ABIM Council. She is also a former Chair of the ABIM Internal Medicine Board.
She received her medical degree from the University of Illinois, Chicago School of Medicine and went on to complete her internship and residency at Beth Israel Hospital, Harvard Medical School.
As of August 2020, Dr. Green reported no external relationships.
C. Seth Landefeld, MD
Dr. Landefeld, board certified in Internal Medicine and Geriatrics, is Professor and Chair, Department of Medicine, University of Alabama at Birmingham (UAB). He serves on the Boards of Directors of the UAB Health System and the University of Alabama Health Services Foundation and is a member of the U.S. Preventive Services Task Force.
Previously, Dr. Landefeld served as Chief of the Division of Geriatrics and Associate Chair for Strategic Planning in the Department of Medicine, University of California, San Francisco (UCSF). He also served as Associate Chief of Staff for Geriatrics and Extended Care, San Francisco VA Medical Center. He was previously Chief, Division of General Internal Medicine and Health Care Research in the Department of Medicine, Case Western Reserve University. Dr. Landefeld practiced general internal medicine and geriatrics in his previous positions; his practice is currently limited to hospital medicine.
Dr. Landefeld has developed novel approaches to improve outcomes of seriously ill older people. He and his colleagues invented Acute Care for Elders Units and demonstrated their beneficial effects for patients, families, physicians and nurses as well as on costs of care. Currently, Dr. Landefeld is a member of the American Board of Internal Medicine Board of Directors. Previously, he served as President of the Society of General Internal Medicine and on the Board of Directors of the American Geriatrics Society. He is the 2016 Laureate, Alabama Chapter, American College of Physicians and an elected member of the American Society for Clinical Investigation and the Association of American Physicians.
Dr. Landefeld received a bachelor’s degree in history and science from Harvard College and his medical degree from Yale University. He also received a bachelor’s degree in philosophy and theology from Oxford University, where he was a Rhodes Scholar. He completed house staff training at University of California San Francisco, where he served as chief medical resident, and fellowship training in general internal medicine and clinical epidemiology at Harvard Medical School and Brigham and Women's Hospital.
As of July 2020, Dr. Landefeld reported the following external relationships:
Work as an author or editor for following company, with compensation as listed:
- McGraw-Hill, receiving compensation as an author for a chapter in Current Diagnosis and Treatment: Geriatrics, 2nd edition.
Dr. Landefeld also serves on the Boards of Directors of the University of Alabama-Birmingham Health System and of the University of Alabama Health Services Foundation.
Dr. Landefeld serves on the United States Preventive Services Task Force, which is supported by the Agency for Healthcare Research and Quality, receiving reimbursement for travel expenses and honoraria for attending meetings.
Robert D. Siegel, MD
Dr. Siegel, a board certified internist, hematologist and medical oncologist, is the Oncology Program Director for the Bon Secours St. Francis Health System in Greenville, South Carolina. Prior to his appointment to program leadership at St. Francis, Dr. Siegel had been a community-based oncologist with particular interest in quality improvement initiatives and cancer care delivery research.
Dr. Siegel has served the American Board of Internal Medicine (ABIM) as a member of the Medical Oncology Exam Writing Committee and is currently chair of its Medical Oncology Board. In July 2015, he was elected to serve on the ABIM Board of Directors. He has previously served as the co-Chair of the Quality of Care Subcommittee for the National Cancer Institute's Community Cancer Centers Program and is currently on the Executive Committee for Southeast Consortium for Oncology Research.
Dr. Siegel earned his medical degree at the Columbia University College of Physicians and Surgeons and did his internal medicine training at Barnes-Jewish Hospital/Washington University in St. Louis. He completed his fellowship training in medical oncology and hematology at the Dana-Farber Cancer Institute/Brigham and Women's Hospital/Harvard University.
As of February 2020, Dr. Siegel reported the following external relationships:
Funding for clinical trial expenses and staff, paid to Bon Secours St. Francis Hospital, from the following companies:
- Bristol-Myers Squibb, for a lung cancer clinical trial, kidney cancer clinical trial, and for a non-Hodgkin lymphoma clinical trial.
- Cancer Insight, for a melanoma clinical trial.
- Merck, for clinical trials for head and neck carcinoma, breast carcinoma, extensive stage small lung cancer, and stomach cancer clinical trials.
- Mirati Therapeutics, for a clinical trial for solid tumors.
- Biodesix, for an observational study assessing the clinical effectiveness of validating immunotherapy tests in subject with non-small cell lung cancer.
- CerRX Inc., for a Phase II trial of intravenous fenretinide emulsion for patients with relapsed/refractory peripheral T-cell lymphomas.
- Boston Biomedical, for a Phase II trial of metastatic pancreatic ductal adenocarcinoma.
- GRAIL, Inc., for a trial of use deep sequencing of circulating cell-free nucleic acids to develop assays to detect cancer early in blood.
- Pharmatech, for a trial of the treatment of cutaneous T-cell lymphoma.
- Altor Bioscience, for two studies on advanced and metastatic non-small lung cancer.
- AstraZeneca, for a study of durvalumab +tremelimumab combination therapy or durvalumab monotherapy in advanced solid malignancies.
- Calithera Biosciences, for a study of advanced or metastatic renal cell carcinoma.
- Galera Therapeutics, for a study of locally advanced, non-metastatic squamous cell carcinoma of the oral cavity or oropharynx, and for a study of incidence of esophagitis in in patients receiving chemoradiotherapy for lung cancer.
- Apollomics, for a study of non-small cell lung cancer with c-Met EXON 14 skip mutations and c-Met dysregulation advanced solid tumors.
- Exact Science, for blood sample collection to evaluate biomarkers in subjects with untreated hematologic malignancies.
- Strata Oncology, for a study of molecular profiling of biospecimens from cancer patients to assist in screening for clinical trial enrollment.
- Arcus, for a Phase 1b study to evaluate the safety and clinical activity of AB122 in biomarker-selected participants with advanced solid tumors.
- Summit, for a study on patients with solid tumors with somatic human epidermal growth factor receptor (EGFR, HER2, HER3) mutations of EGFR gene amplification.
Dr. Siegel serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American Society for Clinical Oncology, Past Chair of Quality Oncology Practice Initiative Certification Oversight Committee, Chair Elect Quality Oncology Practice Initiative Steering Group, Quality Care Committee Member, and International Quality Task Force Member, receiving reimbursement for travel expenses.
- Guardian Research Network, Board of Directors, without compensation.
- Southeastern Health Partners, Board of Directors, without compensation.